What is the Org number of KanMed Aktiebolag?

KanMed Aktiebolag is registered with Bolagsverket / SCB under Org 5561881060.

What is the revenue of KanMed Aktiebolag?

KanMed Aktiebolag reported revenue of SEK 38M in 2024.

How many employees does KanMed Aktiebolag have?

KanMed Aktiebolag employs 9 people as of the latest annual report.

Who is the CEO of KanMed Aktiebolag?

Alan Marcus Nanayakkara is Chief Executive Officer of KanMed Aktiebolag, in role since 2022.

Who is the chairman of KanMed Aktiebolag?

Eberhard Schneider chairs the board of KanMed Aktiebolag, in role since 2022.

Where is KanMed Aktiebolag headquartered?

KanMed Aktiebolag's registered address is Hammarbacken 6 A.

Riskpilot← Back to search

Sign inGet full access

KanMed Aktiebolag

ABActive

Org 5561881060Hammarbacken 6 A, 191 49 SollentunaWholesale of pharmaceutical and medical goods · NACE 4646Est. 19749 employees

Overview Financials People & ownership Related companies

Financials

Revenue

SEK millions

EBITDA

SEK millions

Income statement

SEK thousands

Item	2020	2021	2022	2023	2024
Revenue	26 841	33 188	37 935	42 197	37 966
Staff expenses	—	—	—	—	−9 836
EBITDA	3 760	4 584	3 965	5 863	4 671
Depreciation & amort.	−0	−0	−71	−521	−910
EBIT	3 760	4 584	3 894	5 342	3 761
Net financials	−127	−51	−48	−451	−389
Profit before tax	2 846	3 832	3 336	3 593	2 576
Tax	−622	−822	−751	−802	−603
Net profit	2 224	3 010	2 585	2 791	1 974

Balance sheet

SEK thousands

Item	2020	2021	2022	2023	2024
Total assets	12 443	13 614	16 988	24 241	27 208
Equity	4 819	6 329	6 914	9 704	9 378
Long-term debt	1 115	0	0	3 740	6 399
Short-term debt	4 079	4 155	6 435	5 859	5 697
Total debt	5 194	4 155	6 435	9 599	12 097

Financial ratios

5-year trend

EBITDA margin

12.3%

This company

15.8%

Market median

-22% vs market

20202024

Equity ratio

34.5%

This company

38.2%

Market median

+10% vs market

20202024

Return on equity

21.0%

This company

18.4%

Market median

+14% vs market

20202024

Net profit margin

5.2%

This company

8.1%

Market median

-36% vs market

20202024

Asset turnover

1.40×

This company

1.12×

Market median

+25% vs market

20202024

Debt / equity

1.90×

This company

0.62×

Market median

-206% vs market

20202024

Annual reports & filings

Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31

KanMed Aktiebolag

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on KanMed Aktiebolag

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on KanMed Aktiebolag